Literature DB >> 10424284

Differential response of non-transferrin bound iron uptake in rat liver cells on long-term and short-term treatment with iron.

B Scheiber-Mojdehkar1, I Zimmermann, B Dresow, H Goldenberg.   

Abstract

BACKGROUND: Uptake of non-transferrin-bound iron by the liver is important as a clearance mechanism in iron overload. In contrast to physiological uptake via receptor-mediated endocytosis of transferrin, no regulatory mechanisms for this process are known. This study compares the influence of long-term and short-term depletion and loading of hepatocytes with iron on the uptake of non-transferrin bound iron, its affinity, specificity and the interaction with the transferrin-mediated pathways.
METHODS: Rats were fed iron-deficient, normal and 3,5,5-trimethylhexanoyl-ferrocene-containing diets to obtain livers with the corresponding desired status and the hepatocytes from these livers were used for transport studies. Hepatocytes from normal rats were depleted or loaded with iron by short-term treatment with desferrioxamine or ferric ammonium citrate, respectively. Uptake of non-transferrin bound iron was assayed from ferric citrate and from ferric diethylene triammine pentaacetate.
RESULTS: Uptake of non-transferrin-bound iron in hepatocytes could be seen as consisting of a high-affinity (Km=600 nM) and a low-affinity component. Whereas in normal and in iron-starved rats the high-affinity component was more prominent, it disappeared altogether in hepatocytes from rats with iron overload resulting from prolonged feeding with TMH-ferrocene-enriched diet. Overloading also led to loss of inhibition by diferric transferrin, which occured in starved as well as normal cells. In contrast, short-term iron-depletion of isolated hepatocytes with desferrioxamine had only a weak stimulatory effect, whereas treatment with ferric ammonium citrate strongly increased the uptake rates. However, the inhibition by diferric transferrin also disappeared. In both cases, uptake of non-transferrin bound iron was inhibited by apotransferrin.
CONCLUSIONS: Non-transferrin bound iron uptake in liver cells is apparently regulated by the iron status of the liver. The mode of response to iron loading depends on the method of loading in terms of time course and the form of iron used. It cannot be explained by the behavior of the iron regulatory protein, and it is complex, seeming to involve more than one transport system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424284     DOI: 10.1016/s0168-8278(99)80164-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders.

Authors:  Hyeyoung Nam; Chia-Yu Wang; Lin Zhang; Wei Zhang; Shintaro Hojyo; Toshiyuki Fukada; Mitchell D Knutson
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

Review 2.  Liver iron transport.

Authors:  Ross-M Graham; Anita-C-G Chua; Carly-E Herbison; John-K Olynyk; Debbie Trinder
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

3.  Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells.

Authors:  Donald J Messner; Gowsala Sivam; Kris V Kowdley
Journal:  Liver Int       Date:  2008-05-19       Impact factor: 5.828

4.  Longitudinal analysis of heart and liver iron in thalassemia major.

Authors:  Leila J Noetzli; Susan M Carson; Anne S Nord; Thomas D Coates; John C Wood
Journal:  Blood       Date:  2008-07-23       Impact factor: 22.113

5.  Cardiac T2* magnetic resonance analysis of membranous interventricular septum in assessment of cardiac iron overload in pediatric thalassemia patients: A pilot study.

Authors:  Ishan Kumar; Priyanka Aggarwal; Vineeta Gupta; Ashish Verma; Suwen Kumar; Ram C Shukla
Journal:  Indian J Radiol Imaging       Date:  2019 Jan-Mar

6.  Neoplastic transformation of rat liver epithelial cells is enhanced by non-transferrin-bound iron.

Authors:  Donald J Messner; Kris V Kowdley
Journal:  BMC Gastroenterol       Date:  2008-02-06       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.